首页> 美国卫生研究院文献>other >Clinical Implications of Unmasking Dormant Conduction After Circumferential Pulmonary Vein Isolation in Atrial Fibrillation Using Adenosine: A Systematic Review and Meta-Analysis
【2h】

Clinical Implications of Unmasking Dormant Conduction After Circumferential Pulmonary Vein Isolation in Atrial Fibrillation Using Adenosine: A Systematic Review and Meta-Analysis

机译:腺苷对房颤行周向肺静脉隔离后解除休眠传导的临床意义:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: Circumferential pulmonary vein isolation (CPVI) is a routine ablation strategy of atrial fibrillation (AF). The adenosine test can be used to unmask dormant conduction (DC) of pulmonary veins after CPVI, thereby demonstrating possible pulmonary vein re-connection and the need for further ablation. However, whether adenosine test could help improve the long term successful rate of CPVI is still controversial. This systemic review and meta-analysis was to determine the clinical utility of the adenosine test.>Methods: PubMed, EMBASE, Web of Science and Cochrane Library database were searched through July 2016 to identify relevant studies using the keywords “dormant pulmonary vein conduction,” “adenosine test,” “circumferential pulmonary vein isolation,” and “atrial fibrillation.” A random-effects model was used to compare pooled outcomes and tested for heterogeneity.>Results: A total of 17 studies including 5,169 participants were included in the final meta-analysis. Two groups of comparisons were classified: (1) Long-term successful rate in those AF patients underwent CPVI with and without adenosine test [Group A (+) and Group A (−)]; (2) Long-term successful rate in those patients who had adenosine test with and without dormant conduction [Group DC (+) and Group DC (−)]. The overall meta-analysis showed that no significant difference can be observed between Group A (+) and Group A (−) (RR 1.08; 95% CI 0.97–1.19; P = 0.16; I2 = 66%) and between Group DC (+) and Group DC (−) (RR 1.01; 95% CI 0.91–1.12; P = 0.88; I2 = 60%).>Conclusion: Pooled meta-analysis suggested adenosine test may not improve long-term successful rate in AF patients underwent CPVI. Furthermore, AF recurrence may not be decreased by eliminating DC provoked by adenosine, even though adenosine test was applied after CPVI.
机译:>目的:周向肺静脉隔离(CPVI)是房颤(AF)的常规消融策略。腺苷测试可用于掩盖CPVI后肺静脉的休眠传导(DC),从而证明可能存在肺静脉重新连接以及进一步消融的必要性。然而,腺苷测试是否可以帮助提高CPVI的长期成功率仍存在争议。这项系统的审查和荟萃分析旨在确定腺苷试验的临床效用。>方法:检索了截至2016年7月的PubMed,EMBASE,Web of Science和Cochrane图书馆数据库,以使用关键词识别相关研究“休眠的肺静脉传导”,“腺苷测试”,“周向性肺静脉隔离”和“房颤”。 >结果:最终的荟萃分析包括总共17项研究,包括5169名参与者。>结果。分为两组比较:(1)接受和不接受腺苷试验的CPVI房颤患者的长期成功率[A组(+)和A组(-)]; (2)接受和不进行潜伏性传导腺苷测试的患者的长期成功率[DC组(+)和DC组(-)]。总体荟萃分析显示,A组(+)和A组(-)之间没有观察到显着差异(RR 1.08; 95%CI 0.97-1.19; P = 0.16; I 2 = 66%)和DC组(+)与DC组(-)之间(RR 1.01; 95%CI 0.91-1.12; P = 0.88; I 2 = 60%)。>结论: 汇总荟萃分析表明,腺苷测试可能无法提高接受CPVI的房颤患者的长期成功率。此外,即使在CPVI后进行了腺苷试验,通过消除腺苷引起的DC也可能不会降低AF复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号